Imagen de Portada
Código QR

Biobetter Development: Weighing development costs/resources and performance benefits is essential.

Publicado en:BioPharm International Vol. 37; no. 8; pp. 10 - 12
Autor principal: CHALLENER, CYNTHIA A.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Sep2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179650988&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179650988
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Sep2024
      vid: 37
      iid: 8
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        179650988
        179650988
        179650988
        179650988
      ppf: 10
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Biobetter Development: Weighing development costs/resources and performance benefits is essential.
      aug:
        au: CHALLENER, CYNTHIA A.
      sug:
        subj:
          Biological Products Economics
          Drug Development Economics
          Cost Benefit Analysis
          Drug Efficacy
          Biosimilar Pharmaceuticals
          Patents
          Chemistry, Pharmaceutical
          Antibodies, Monoclonal
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N